R3 Stem Cell has been honored with the prestigious Regenerative Medicine Company of the Year Global award by International ...

The SickScience NetWork Rich Concentrated Serum taps exosomes to smooth fine lines and hydrate, plus it even doubles as a makeup primer.

Pluri launches wholly-owned health and aesthetics subsidiary Cellav- leveraging Pluri’s proprietary 3D cell expansion platform to deliver advanced exosome-based technologies for medical aesthetics The ...

Dr. Milligan is fellowship-trained and certified in sports medicine and board-certified in family medicine. He brings more ...

Lifeasible, a leading provider of biological research solutions, has introduced its integrated exosome platform along with an expanded product portfolio, offering researchers flexible and ...

Exosomes, naturally occurring extracellular vesicles, have garnered increasing interest in the field of cosmetics and skincare due to their regenerative properties. These vesicles, derived from skin ...

Skin Science, the fastest-growing professional-grade skincare brand developed by Rion Aesthetics, will participate in the TD Cowen Glowing Ahead Summit: Beauty’s Evolution & Longevity as Luxury, ...

RION's Phase 2A clinical trial focuses on evaluating the safety and efficacy of Platelet Exosome Product™ (PEP™) combined with TISSEEL fibrin sealant for treating Diabetic Foot Ulcers (DFU). Diabetic ...

The license agreement grants PranaX access to a core patent portfolio covering exosome manufacturing, engineering and therapeutic applications through a technology licensing agreement. This agreement ...

ROCHESTER, Minn.--(BUSINESS WIRE)--RION, at the forefront of exosome innovation and therapeutic application, has officially commenced a Phase 1b study aimed at assessing the efficacy and safety of ...

A firsthand account of regenerative aesthetics’ latest development, as Acorn Biolabs banks stem cells from the hair follicle and creates personalized anti-aging “secretome” serums for patients.

Chicago, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The global exosome therapy market was valued at USD 58.1 billion and is set to surpass USD 309.6 billion by 2035 at a CAGR of 18.20% during the forecast ...